Understanding Mass Spectrometry for Biologics
Small molecule drugs continue to dominate the drug pipeline in volume terms, but biologic therapeutics are an alternative, and increasingly important, therapeutic class. Within biologics, a growing number of novel modalities are now emerging, with next-generation biologics incorporating the already heterogeneous features that are present in monoclonal antibodies (mAbs) and other proteins, and adding new … Read more